Cargando…

IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. OBJECTIVE: We sought to validate externally, as well as in patients from the second pandemic wave i...

Descripción completa

Detalles Bibliográficos
Autores principales: Utrero-Rico, Alberto, Ruiz-Hornillos, Javier, González-Cuadrado, Cecilia, Rita, Claudia Geraldine, Almoguera, Berta, Minguez, Pablo, Herrero-González, Antonio, Fernández-Ruiz, Mario, Carretero, Octavio, Taracido-Fernández, Juan Carlos, López-Rodriguez, Rosario, Corton, Marta, Aguado, José María, Villar, Luisa María, Ayuso-García, Carmen, Paz-Artal, Estela, Laguna-Goya, Rocio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919507/
https://www.ncbi.nlm.nih.gov/pubmed/33662370
http://dx.doi.org/10.1016/j.jaci.2021.02.021
_version_ 1783658139667660800
author Utrero-Rico, Alberto
Ruiz-Hornillos, Javier
González-Cuadrado, Cecilia
Rita, Claudia Geraldine
Almoguera, Berta
Minguez, Pablo
Herrero-González, Antonio
Fernández-Ruiz, Mario
Carretero, Octavio
Taracido-Fernández, Juan Carlos
López-Rodriguez, Rosario
Corton, Marta
Aguado, José María
Villar, Luisa María
Ayuso-García, Carmen
Paz-Artal, Estela
Laguna-Goya, Rocio
author_facet Utrero-Rico, Alberto
Ruiz-Hornillos, Javier
González-Cuadrado, Cecilia
Rita, Claudia Geraldine
Almoguera, Berta
Minguez, Pablo
Herrero-González, Antonio
Fernández-Ruiz, Mario
Carretero, Octavio
Taracido-Fernández, Juan Carlos
López-Rodriguez, Rosario
Corton, Marta
Aguado, José María
Villar, Luisa María
Ayuso-García, Carmen
Paz-Artal, Estela
Laguna-Goya, Rocio
author_sort Utrero-Rico, Alberto
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. OBJECTIVE: We sought to validate externally, as well as in patients from the second pandemic wave in Europe, our previously developed mortality prediction model for hospitalized COVID-19 patients. METHODS: Three validation cohorts were generated: 2 external with 185 and 730 patients from the first wave and 1 internal with 119 patients from the second wave. The probability of death was calculated for all subjects using our prediction model, which includes peripheral blood oxygen saturation/fraction of inspired oxygen ratio, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, IL-6, and age. Discrimination and calibration were evaluated in the validation cohorts. The prediction model was updated by reestimating individual risk factor effects in the overall cohort (N = 1477). RESULTS: The mortality prediction model showed good performance in the external validation cohorts 1 and 2, and in the second wave validation cohort 3 (area under the receiver-operating characteristic curve, 0.94, 0.86, and 0.86, respectively), with excellent calibration (calibration slope, 0.86, 0.94, and 0.79; intercept, 0.05, 0.03, and 0.10, respectively). The updated model accurately predicted mortality in the overall cohort (area under the receiver-operating characteristic curve, 0.91), which included patients from both the first and second COVID-19 waves. The updated model was also useful to predict fatal outcome in patients without respiratory distress at the time of evaluation. CONCLUSIONS: This is the first COVID-19 mortality prediction model validated in patients from the first and second pandemic waves. The COR+12 online calculator is freely available to facilitate its implementation (https://utrero-rico.shinyapps.io/COR12_Score/).
format Online
Article
Text
id pubmed-7919507
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-79195072021-03-01 IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts Utrero-Rico, Alberto Ruiz-Hornillos, Javier González-Cuadrado, Cecilia Rita, Claudia Geraldine Almoguera, Berta Minguez, Pablo Herrero-González, Antonio Fernández-Ruiz, Mario Carretero, Octavio Taracido-Fernández, Juan Carlos López-Rodriguez, Rosario Corton, Marta Aguado, José María Villar, Luisa María Ayuso-García, Carmen Paz-Artal, Estela Laguna-Goya, Rocio J Allergy Clin Immunol Covid-19 BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. OBJECTIVE: We sought to validate externally, as well as in patients from the second pandemic wave in Europe, our previously developed mortality prediction model for hospitalized COVID-19 patients. METHODS: Three validation cohorts were generated: 2 external with 185 and 730 patients from the first wave and 1 internal with 119 patients from the second wave. The probability of death was calculated for all subjects using our prediction model, which includes peripheral blood oxygen saturation/fraction of inspired oxygen ratio, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, IL-6, and age. Discrimination and calibration were evaluated in the validation cohorts. The prediction model was updated by reestimating individual risk factor effects in the overall cohort (N = 1477). RESULTS: The mortality prediction model showed good performance in the external validation cohorts 1 and 2, and in the second wave validation cohort 3 (area under the receiver-operating characteristic curve, 0.94, 0.86, and 0.86, respectively), with excellent calibration (calibration slope, 0.86, 0.94, and 0.79; intercept, 0.05, 0.03, and 0.10, respectively). The updated model accurately predicted mortality in the overall cohort (area under the receiver-operating characteristic curve, 0.91), which included patients from both the first and second COVID-19 waves. The updated model was also useful to predict fatal outcome in patients without respiratory distress at the time of evaluation. CONCLUSIONS: This is the first COVID-19 mortality prediction model validated in patients from the first and second pandemic waves. The COR+12 online calculator is freely available to facilitate its implementation (https://utrero-rico.shinyapps.io/COR12_Score/). American Academy of Allergy, Asthma & Immunology 2021-05 2021-03-01 /pmc/articles/PMC7919507/ /pubmed/33662370 http://dx.doi.org/10.1016/j.jaci.2021.02.021 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19
Utrero-Rico, Alberto
Ruiz-Hornillos, Javier
González-Cuadrado, Cecilia
Rita, Claudia Geraldine
Almoguera, Berta
Minguez, Pablo
Herrero-González, Antonio
Fernández-Ruiz, Mario
Carretero, Octavio
Taracido-Fernández, Juan Carlos
López-Rodriguez, Rosario
Corton, Marta
Aguado, José María
Villar, Luisa María
Ayuso-García, Carmen
Paz-Artal, Estela
Laguna-Goya, Rocio
IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
title IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
title_full IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
title_fullStr IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
title_full_unstemmed IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
title_short IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts
title_sort il-6–based mortality prediction model for covid-19: validation and update in multicenter and second wave cohorts
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919507/
https://www.ncbi.nlm.nih.gov/pubmed/33662370
http://dx.doi.org/10.1016/j.jaci.2021.02.021
work_keys_str_mv AT utreroricoalberto il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT ruizhornillosjavier il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT gonzalezcuadradocecilia il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT ritaclaudiageraldine il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT almogueraberta il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT minguezpablo il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT herrerogonzalezantonio il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT fernandezruizmario il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT carreterooctavio il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT taracidofernandezjuancarlos il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT lopezrodriguezrosario il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT cortonmarta il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT aguadojosemaria il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT villarluisamaria il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT ayusogarciacarmen il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT pazartalestela il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts
AT lagunagoyarocio il6basedmortalitypredictionmodelforcovid19validationandupdateinmulticenterandsecondwavecohorts